Li Dandan, Nishi Stephanie K, Jovanovski Elena, Zurbau Andreea, Komishon Allison, Mejia Sonia Blanco, Khan Tauseef A, Sievenpiper John L, Milicic Davor, Jenkins Alexandra, Vuksan Vladimir
Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Unity Health.
Department of Nutritional Sciences, Faculty of Medicine, University of Toronto.
J Hypertens. 2020 Nov;38(11):2122-2140. doi: 10.1097/HJH.0000000000002524.
We aim to synthesize effects of repeated administration (≥3 days) of inorganic nitrate on blood pressure and arterial stiffness measures.
We conducted a systematic review and meta-analysis of randomized controlled trials with at least 3 days treatment of inorganic nitrate on blood pressure and arterial stiffness in individuals with or without elevated cardiovascular disease risk. MEDLINE, EMBASE and the Cochrane Library were searched through 2 July 2019. Two independent reviewers extracted relevant study data. Data were pooled using the generic inverse variance method with random-effects model, and expressed as mean differences with 95% confidence intervals. Certainty in the evidence was assessed using GRADE.
Forty-seven trials were included (n = 1101). Administration of inorganic nitrate significantly lowered SBP [mean difference: -2.91 mmHg, 95% confidence interval (95% CI): -3.92 to -1.89, I = 76%], DBP (mean difference: -1.45 mmHg, 95% CI: -2.22 to -0.68, I = 78%], central SBP (mean difference: -1.56 mmHg, 95% CI: -2.62 to -0.50, I = 30%) and central DBP (mean difference: -1.99 mmHg, 95% CI: -2.37 to -1.60, I = 0%). There was no effect on 24-h blood pressure, augmentation index or pulse wave velocity. Certainty in the evidence was graded moderate for central blood pressure, pulse wave velocity and low for peripheral blood pressure, 24-h blood pressure and augmentation index.
Repeated administration (≥3 days) of inorganic nitrate lower peripheral and central blood pressure. Results appear to be driven by beneficial effects in healthy and hypertensive individuals. More studies are required to increase certainty in the evidence.
我们旨在综合评估重复给药(≥3天)无机硝酸盐对血压和动脉僵硬度指标的影响。
我们对随机对照试验进行了系统评价和荟萃分析,这些试验对有或无心血管疾病风险升高的个体进行了至少3天的无机硝酸盐治疗,以观察其对血压和动脉僵硬度的影响。检索了截至2019年7月2日的MEDLINE、EMBASE和Cochrane图书馆。两名独立的评审员提取了相关研究数据。使用通用逆方差法和随机效应模型汇总数据,并以95%置信区间的均值差异表示。使用GRADE评估证据的确定性。
纳入了47项试验(n = 1101)。给予无机硝酸盐可显著降低收缩压[均值差异:-2.91 mmHg,95%置信区间(95%CI):-3.92至-1.89,I = 76%]、舒张压(均值差异:-1.45 mmHg,95%CI:-2.22至-0.68,I = 78%)、中心收缩压(均值差异:-1.56 mmHg,95%CI:-2.62至-0.50,I = 30%)和中心舒张压(均值差异:-1.99 mmHg,95%CI:-2.37至-1.60,I = 0%)。对24小时血压、增强指数或脉搏波速度没有影响。中心血压、脉搏波速度的证据确定性为中等,外周血压、24小时血压和增强指数的证据确定性为低。
重复给药(≥3天)无机硝酸盐可降低外周和中心血压。结果似乎是由对健康个体和高血压个体的有益作用驱动的。需要更多的研究来提高证据的确定性。